• AXIS Clinicals successfully completes 14th US FDA audit (June 2016)
  • AXIS Clinicals successfully completes US FDA audit for ICP-OES services (March 2016)
  • AXIS Clinicals successfully completes 7th ANVISA – Brazil audit (March 2015)
  • AXIS Clinicals successfully completes WHO audit (March 2015)
  • AXIS Clinicals successfully completes 3rd MHRA audit (Sep 2014)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Global Locations

India :
The operations in India has been running since 2004, providing expert, innovative clinical services and solutions for customers. Our office houses approx. 300 people including highly trained clinical research professionals, project managers, and skilled Bio-Analytical scientists. With dedicated PK/Statistics and Clinical Data Management team, the company offers end-to-end solution to customers. AXIS Clinicals has a total floor area of approximately 210000 sft in India. at its Indian facility that houses approx. 300 beds and 18 modern LC/MS-MS systems.

Contact:
Mr. Abhijit Chaudhari
Director – Business Development
AXIS Clinicals Limited
1-121/1, Survey No.66 (Part) & 67(Part),
Miyapur, Serilingampally, Hyderabad
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


United States :

Our soon to start Fargo (North Dakota) facility is a 300 bed clinical facility spread in an area of approx. 120,000 sq. ft. This would house nearly 15 LC/MS-MS machines and have a dedicated Medical writing and PK/Stats team. We would offer the following specialized services to our client’s in addition to regular BA/BE studies:

  • Dermal PK (safety and efficacy studies)
  • Dermal adhesion (FDA Standard and Dot Adhesion models)
  • Cumulative irritation and HRIPT studies
  • Dermatopharmacokinetic (DPK) tape stripping studies (often driven by protocol requirements)
  • Vasoconstriction studies

Contact:
Mr. Sidharth Mishra
Director – Business Development (U.S)
AXIS Clinicals Ltd.
1711 Highway 10 East, Dilworth,
Minnesota, U.S.A
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


Mexico :

AXIS, Latina started operations in 2011 and equipped with 130 beds in +40,000 sq. ft. clinic area and the Bio-Analytical lab is equipped with four modern LC/MS-MS systems. With +70 people team at Mexico, we are catering to the clinical development needs of major local and international generic players for registration of their products in Mexican and other Latin American market.

Contact:
Jose Eric Lopez Canseco
Manager – Business Development
AXIS Clinicals Latina.
Ing. Basiliso Romo Anguiano,
225 Col. Gpe. Insurgentes, Del. G.A. Madero; C.P. 07870,
México D.F., MÉXICO
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 

 

Fact sheet

  • Over 1,600 clinical studies completed since inception
  • Over 290 bioanalytical methods developed
  • Over 38 successful Regulatory audits
  • Global footprint of operations with sites in India, U.S, Mexico & Thailand.
  • Two clinical facilities in India
  • 60+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 200+ approvals, EMEA : 70+ approvals, Canada : 20+ approvals, Australia : 30+ approvals
  • 350+ staff working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved

Design By Graypixel